First-Trimester Genetic Counseling: Perspectives and ConsiderationsPERGAMENT, Eugene.Clinics in laboratory medicine. 2010, Vol 30, Num 3, issn 0272-2712, vii-viii, 557-563 [9 p.]Article

Adverse Pregnancy Outcomes After Abnormal First-Trimester Screening for AneuploidyGOETZL, Laura.Clinics in laboratory medicine. 2010, Vol 30, Num 3, issn 0272-2712, ix, 613-628 [17 p.]Article

Monitoring Quality Control of Nuchal TranslucencyCUCKLE, Howard.Clinics in laboratory medicine. 2010, Vol 30, Num 3, issn 0272-2712, viii-ix, 593-604 [14 p.]Article

Prenatal Screening and DiagnosisODIBO, Anthony O; KRANTZ, David A.Clinics in laboratory medicine. 2010, Vol 30, Num 3, issn 0272-2712, 267 p.Serial Issue

Screening for Open Neural Tube DefectsKRANTZ, David A; HALLAHAN, Terrence W; SHERWIN, John E et al.Clinics in laboratory medicine. 2010, Vol 30, Num 3, issn 0272-2712, xi-xii, 721-725 [7 p.]Article

Biophysical and Biochemical Screening for the Risk of Preterm LaborWAX, Joseph R; CARTIN, Angelina; PINETTE, Michael G et al.Clinics in laboratory medicine. 2010, Vol 30, Num 3, issn 0272-2712, xi, 693-707 [16 p.]Article

Combined first-trimester versus second-trimester serum screening for Down syndrome: A cost analysisCUSICK, William; BUCHANAN, Philip; HALLAHAN, Terrence W et al.American journal of obstetrics and gynecology. 2003, Vol 188, Num 3, pp 745-751, issn 0002-9378, 7 p.Article

Additional First-Trimester Ultrasound MarkersSONEK, J; NICOLAIDES, K.Clinics in laboratory medicine. 2010, Vol 30, Num 3, issn 0272-2712, viii, 573-592 [21 p.]Article

First-Trimester Screening for Chromosomal Abnormalities: Advantages of an Instant Results ApproachNORTON, Mary E.Clinics in laboratory medicine. 2010, Vol 30, Num 3, issn 0272-2712, viii, 565-571 [8 p.]Article

Clinical Implications of First-Trimester ScreeningCHASEN, Stephen T.Clinics in laboratory medicine. 2010, Vol 30, Num 3, issn 0272-2712, ix, 605-611 [8 p.]Article

First-trimester screening in tripletsKRANTZ, David A; HALLAHAN, Terrence W; KUANGLIN HE et al.American journal of obstetrics and gynecology. 2011, Vol 205, Num 4, pp 364-366, issn 0002-9378, 3 p.Conference Paper

Toxoplasmosis, Parvovirus, and Cytomegalovirus in PregnancyFELDMAN, Deborah M; TIMMS, Diane; BORGIDA, Adam F et al.Clinics in laboratory medicine. 2010, Vol 30, Num 3, issn 0272-2712, xi, 709-720 [13 p.]Article

First-trimester Down syndrome screening using dried blood biochemistry and nuchal translucencyKRANTZ, David A; HALLAHAN, Terrence W; ORLANDI, Francesco et al.Obstetrics and gynecology (New York. 1953). 2000, Vol 96, Num 2, pp 207-213, issn 0029-7844Article

Undermeasurement of Nuchal Translucencies: Implications for ScreeningEVANS, Mark I; KRANTZ, David A; HALLAHAN, Terrence W et al.Obstetrics and gynecology (New York. 1953). 2010, Vol 116, Num 4, pp 815-818, issn 0029-7844, 4 p.Article

An Overview of First-Trimester Screening for Chromosomal AbnormalitiesBAHADO-SINGH, Ray O; ARGOTI, Pedro.Clinics in laboratory medicine. 2010, Vol 30, Num 3, issn 0272-2712, vii, 545-555 [12 p.]Article

Modifying Risk for Aneuploidy with Second-Trimester Ultrasound After a Positive Serum ScreenTIMMS, Diane; CAMPBELL, Winston A.Clinics in laboratory medicine. 2010, Vol 30, Num 3, issn 0272-2712, x-xi, 677-692 [18 p.]Article

First-trimester screening for trisomy-21 using a simplified method to assess the presence or absence of the fetal nasal boneORLANDI, Francesco; ROSSI, Cinzia; ORLANDI, Emanuela et al.American journal of obstetrics and gynecology. 2005, Vol 192, Num 4, pp 1107-1111, issn 0002-9378, 5 p.Article

Quality of Nuchal Translucency Measurements Correlates with Broader Aspects of Program Rigor and Culture of ExcellenceEVANS, Mark I; KRANTZ, David A; HALLAHAN, Terrence et al.Fetal diagnosis and therapy. 2013, Vol 33, Num 4, pp 230-234, issn 1015-3837, 5 p.Article

An Update on Cystic Fibrosis ScreeningGOETZINGER, Katherine R; CAHILL, Alison G.Clinics in laboratory medicine. 2010, Vol 30, Num 3, issn 0272-2712, vii, 533-543 [12 p.]Article

Maternal weight and ethnic adjustment within a first-trimester Down syndrome and trisomy 18 screening programKRANTZ, David A; HALLAHAN, Terrence W; MACRI, V. James et al.Prenatal diagnosis. 2005, Vol 25, Num 8, pp 635-640, issn 0197-3851, 6 p.Article

Cost-Effectiveness of Down Syndrome Screening ParadigmsCAUGHEY, Aaron B; KAIMAL, Anjali J; ODIBO, Anthony O et al.Clinics in laboratory medicine. 2010, Vol 30, Num 3, issn 0272-2712, ix-x, 629-642 [16 p.]Article

Screening and Testing in MultiplesEVANS, Mark I; ANDRIOLE, Stephanie.Clinics in laboratory medicine. 2010, Vol 30, Num 3, issn 0272-2712, x, 643-654 [13 p.]Article

Meta-analysis of first trimester Down syndrome screening studies : free β-human chorionic gonadotropin significantly outperforms intact human chorionic gonadotropin in a multimarker protocolEVANS, Mark I; KRANTZ, David A; HALLAHAN, Terrence W et al.American journal of obstetrics and gynecology. 2007, Vol 196, Num 3, pp 198-205, issn 0002-9378, 8 p.Article

Preimplantation Genetic Testing: Indications and ControversiesCOOPER, Amber R; JUNGHEIM, Emily S.Clinics in laboratory medicine. 2010, Vol 30, Num 3, issn 0272-2712, vii, 519-531 [13 p.]Article

Noninvasive Prenatal Diagnosis: 2010EVANS, Mark I; KILPATRICK, Michael.Clinics in laboratory medicine. 2010, Vol 30, Num 3, issn 0272-2712, x, 655-665 [12 p.]Article